ArticleOncoTargets and therapy2023

Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center Study.

Zhitao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.